Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Apr 1;146(7):1177–1182.

The comparative efficacy of trazodone and imipramine in the treatment of depression.

S B Patten 1
PMCID: PMC1488340  PMID: 1532532

Abstract

OBJECTIVE: To review published clinical trials comparing the efficacy of trazodone with that of tricyclic antidepressant medication. DATA SOURCES: MEDLINE was searched for relevant articles published from 1983 to 1991. The bibliography of a review article was searched for further references. STUDY SELECTION: In all, 25 clinical trials were found. Six of these met the methodologic assessment criteria (adapted from the McMaster guidelines for the evaluation of clinical trials), which included the stipulation of a score of 18 or more on the Hamilton depression rating scale and a 50% reduction in that score as an outcome measure. DATA EXTRACTION: All six studies compared trazodone with imipramine. Data describing response to the treatments were extracted, and post-hoc power estimates were calculated. The analysis also involved statistical tests of a modified null hypothesis, the generation of confidence intervals (CIs) and a meta-analysis. DATA SYNTHESIS: All the studies found no significant difference in the efficacy of trazodone and imipramine. However, the statistical power of most of them was less than 50% and often less than 10%; thus there was a low probability that differences would be detected. The results of statistical tests of the modified null hypothesis, inspection of the CIs and the results of the meta-analysis all suggested that trazodone, and imipramine are equally efficacious. CONCLUSION: The application of various techniques for the analysis of equivalence data suggests that trazodone and imipramine are of approximately equivalent efficacy. The data are compatible with small differences in efficacy, but the differences are of a magnitude such that they are unlikely to be of clinical significance.

Full text

PDF
1179

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackwelder W. C. "Proving the null hypothesis" in clinical trials. Control Clin Trials. 1982 Dec;3(4):345–353. doi: 10.1016/0197-2456(82)90024-1. [DOI] [PubMed] [Google Scholar]
  2. Escobar J. I., Gomez J., Constain C., Rey J., Santacruz H. Controlled clinical trial with trazodone, a novel antidepressant. A South American experience. J Clin Pharmacol. 1980 Feb-Mar;20(2-3):124–130. doi: 10.1002/j.1552-4604.1980.tb02534.x. [DOI] [PubMed] [Google Scholar]
  3. Feighner J. P. Trazodone, a triazolopyridine derivative, in primary depressive disorder. J Clin Psychiatry. 1980 Jul;41(7):250–255. [PubMed] [Google Scholar]
  4. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kellams J. J., Klapper M. H., Small J. G. Trazodone, a new antidepressant: efficacy and safety in endogenous depression. J Clin Psychiatry. 1979 Sep;40(9):390–395. [PubMed] [Google Scholar]
  6. Makuch R., Johnson M. Issues in planning and interpreting active control equivalence studies. J Clin Epidemiol. 1989;42(6):503–511. doi: 10.1016/0895-4356(89)90146-7. [DOI] [PubMed] [Google Scholar]
  7. Robins J., Breslow N., Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics. 1986 Jun;42(2):311–323. [PubMed] [Google Scholar]
  8. Rudorfer M. V., Golden R. N., Potter W. Z. Second-generation antidepressants. Psychiatr Clin North Am. 1984 Sep;7(3):519–534. [PubMed] [Google Scholar]
  9. Scher M., Krieger J. N., Juergens S. Trazodone and priapism. Am J Psychiatry. 1983 Oct;140(10):1362–1363. doi: 10.1176/ajp.140.10.1362. [DOI] [PubMed] [Google Scholar]
  10. Shopsin B. Second generation antidepressants. J Clin Psychiatry. 1980 Dec;41(12 Pt 2):45–56. [PubMed] [Google Scholar]
  11. Spitzer R. L., Endicott J., Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978 Jun;35(6):773–782. doi: 10.1001/archpsyc.1978.01770300115013. [DOI] [PubMed] [Google Scholar]
  12. Trapp G. A., Handorf C. R., Larach V. Trazodone in the treatment of depressed inpatients. Psychopharmacol Bull. 1979 Jul;15(3):25–27. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES